Skip to main content
Log in

Studies on the emergence of resistance to lomefloxacin in vitro

  • Notes
  • New Antimicrobial Agents
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

    We’re sorry, something doesn't seem to be working properly.

    Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

Abstract

The emergence of resistance to lomefloxacin, norfloxacin and ciprofloxacin was investigated in nalidixic acid sensitive and resistant urinary isolates by continuous turbidimetry. A decline in susceptibility was observed after a single exposure to each of the drugs, and further increments of resistance occurred during three sequential passages. Variants resistant to one quinolone were cross-resistant to the others. The level of resistance selected by norfloxacin in three of the five test strains was greater than that observed with lomefloxacin or ciprofloxacin. In experiments in a model of the treatment of bacterial cystitis, concentrations of lomefloxacin well within those readily achievable in urine suppressed growth of nalidixic acid sensitive and resistant strains for more than 20 h without causing any decline in susceptibility of surviving bacteria.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tenney, J. H., Maack, R. W., Chippendale, G. R.: Rapid selection of organisms with increasing resistance on subinhibitory concentrations of norfloxacin in agar. Antimicrobial Agents and Chemotherapy 1983, 23: 188–189.

    Google Scholar 

  2. Barry, A. L., Jones, R. N.: Cross-resistance among cinoxacin, ciprofloxacin, DJ-6783, enoxacin, nalidixic acid, norfloxacin and oxolinic acid after in vitro selection of resistant populations. Antimicrobial Agents and Chemotherapy 1984, 25: 775–777.

    Google Scholar 

  3. Limb, D. I., Dabbs, D. J. W., Spencer, R. C.: In vitro selection of bacteria resistant to the 4-quinolone agents. Journal of Antimicrobial Chemotherapy 1987, 19: 65–71.

    Google Scholar 

  4. Chapman, S. T., Speller, D. C. E., Reeves, D. S.: Resistance to ciprofloxacin. Lancet 1985, ii: 39.

    Google Scholar 

  5. Follath, F., Bindschedler, M., Wenk, M., Frei, R., Stalder, H., Reber, H.: Use of ciprofloxacin in the treatment ofPseudomonas aeruginosa infection. European Journal of Clinical Microbiology 1986, 5: 236–240.

    Google Scholar 

  6. Hirose, T., Okezaki, H., Kato, H., Ito, Y., Inoue, M., Mitsuhashi, S.: In vitro and in vivo activity of NY-198, a new difluorinated quinolone. Antimicrobial Agents and Chemotherapy 1987, 31: 854–859.

    Google Scholar 

  7. Wise, R., Andrews, J. M., Ashby, J. P., Matthews, R. S.: In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents. Antimicrobial Agents and Chemotherapy 1988, 32: 617–622.

    Google Scholar 

  8. Chin, N. X., Novelli, A., Neu, H. C.: In vitro activity of lomefloxacin (SC-4711; NY-198), a difluoroquinolone 3-carboxylic acid, compared with those of other quinolones. Antimicrobial Agents and Chemotherapy 1988, 32: 656–662.

    Google Scholar 

  9. Edwards, R., Kanematsu, M., Greenwood, D.: Laboratory assessment of lomefloxacin (SC-47111) in comparison with norfloxacin. Journal of Antimicrobial Chemotherapy 1988, 22: 885–890.

    Google Scholar 

  10. Greenwood, D., O'Grady, F.: An in vitro model of the urinary bladder. Journal of Antimicrobial Chemotherapy 1978, 4: 113–120.

    Google Scholar 

  11. Greenwood, D., Osman, M., Goodwin, J., Cowlishaw, W. A., Slack, R.: Norfloxacin: activity against urinary tract pathogens and factors influencing the emergence of resistance. Journal of Antimicrobial Chemotherapy 1984, 13: 315–323.

    Google Scholar 

  12. Greenwood, D., O'Grady, F.: Comparison of the response ofEscherichia coli andProteus mirabilis to seven β-lactam antibiotics. Journal of Infectious Diseases 1973, 128: 211–222.

    Google Scholar 

  13. Mackintosh, I. P., O'Grady, F., Greenwood, D., Watson, B. W., Crichton, T. C., Piper, R., Ferrer, A.: A twelve channel bacterial growth monitoring system. Biomedical Engineering 1973, 8: 514–515 and 526.

    Google Scholar 

  14. Greenwood, D., O'Grady, F.: Factors governing the emergence of resistance to nalidixic acid in treatment of urinary tract infection. Antimicrobial Agents and Chemotherapy 1977, 12: 678–681.

    Google Scholar 

  15. Teoh-Chan, C. H., Cowlishaw, A., Eley, A., Slater, G., Greenwood, D.: Laboratory evaluation of enoxacin: comparison with norfloxacin and nalidixic acid. Journal of Antimicrobial Chemotherapy 1985, 15: 45–52.

    Google Scholar 

  16. Shiba, K., Saito, A., Shimada, J., Miyahara, T., Makino, E., Okezaki, E.: Pharmacokinetics of NY-198, a new quinolone agent, in healthy adult volunteers. In: Berkada, B., Kuemmerle, H.-P. (ed.): Progress in antimicrobial and anticancer chemotherapy. Ecomed, Landsberg, 1987, p. 1847–1849.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kanematsu, M., Greenwood, D. Studies on the emergence of resistance to lomefloxacin in vitro. Eur. J. Clin. Microbiol. Infect. Dis. 8, 741–745 (1989). https://doi.org/10.1007/BF01963766

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01963766

Keywords

Navigation